AGMB · Categories · Form 3
AGMB - SEC Form 3 initial insider statements
AgomAb Therapeutics NV (AGMB) sec form 3 initial insider statements - real-time wire coverage filtered to Form 3 only.
Recent Form 3 for AGMB
- SEC Form 3 filed by new insider Bond Colin Michael3 - Agomab Therapeutics NV (0002020932) (Issuer)
- SEC Form 3 filed by new insider Van Der Horst Paul Henryk3 - Agomab Therapeutics NV (0002020932) (Issuer)
- SEC Form 3 filed by new insider Knotnerus Tim Jasper3 - Agomab Therapeutics NV (0002020932) (Issuer)
- SEC Form 3 filed by new insider Borderias Andrea Saez3 - Agomab Therapeutics NV (0002020932) (Issuer)
- SEC Form 3 filed by new insider Verduyn-Van Weegen Felice Isabel3 - Agomab Therapeutics NV (0002020932) (Issuer)
- SEC Form 3 filed by new insider Epstein David R3 - Agomab Therapeutics NV (0002020932) (Issuer)
- SEC Form 3 filed by new insider Lefever Ellen3 - Agomab Therapeutics NV (0002020932) (Issuer)
- SEC Form 3 filed by new insider Hammer Ohad3 - Agomab Therapeutics NV (0002020932) (Issuer)
- SEC Form 3 filed by new insider Kemula Pierre Thadee Victor3 - Agomab Therapeutics NV (0002020932) (Issuer)
- SEC Form 3 filed by new insider Wiesel Philippe Constantin3 - Agomab Therapeutics NV (0002020932) (Issuer)
- SEC Form 3 filed by new insider Jahreis Angelika Martha3 - Agomab Therapeutics NV (0002020932) (Issuer)